BLRX.TA Gross Margin

The Gross Margin of BioLine RX Ltd (BLRX.TA) is 67.99%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

BLRX.TA Gross Margin - Historical Value

Date	Value
2024-12-31	67.99%
2023-12-31	23.08%

BLRX.TA Gross Margin - Peers Comparison

Ticker	Name	Value
HESTERBIO.NS	Hester Biosciences Ltd	59.87%
138610.KQ	Nibec Co Ltd	51.65%
4599.T	StemRIM Inc	100.00%
166480.KQ	Corestemchemon Inc	-3.89%
1672.HK	Ascletis Pharma Inc	57.29%
4883.T	Modalis Therapeutics Corp	100.00%
000004.SZ	Shenzhen GuoHua Network Security Technology Co Ltd	57.60%
031390.KQ	Green Cross Cell Corp	39.84%
244460.KQ	OliPass Corp	89.51%
290650.KQ	L&C Bio Co Ltd	50.49%
011000.KS	Gene One Life Science Inc	-30.43%
065660.KQ	Anterogen Co Ltd	37.91%
185490.KQ	EyeGene Inc	34.50%
256840.KQ	BNC Korea Co Ltd	44.82%
7774.T	Japan Tissue Engineering Co Ltd	67.24%
BONS.TA	Bonus Biogroup Ltd	10.93%
174900.KQ	AbClon Inc	46.02%
191420.KQ	Tego Science Inc	70.67%
CANF.TA	Can Fite Biopharma Ltd	90.62%
263050.KQ	Eutilex Co Ltd	6.56%
UNVO.TA	Univo Pharmaceuticals Ltd	32.29%
002868.SZ	Lifecome Biochemistry Co Ltd	-20.66%
228760.KQ	Genomictree Inc	-30.76%
086890.KQ	Isu Abxis Co Ltd	71.93%
304840.KQ	PeopleBio Inc	36.22%
4978.T	ReproCell Inc	46.19%
086820.KQ	Bio Solution Co Ltd	65.16%